Landscapes / Companies
Tango Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
Drugs
3
in active trials · 5 in all
Trials
5 active
7 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 31 Mar 2027Phase 1/2 trial completes | |||
| Next date | 31 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme and 5 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 1 May 2027Phase 1/2 trial completes | |||
| Next date | 1 May 2027 · Phase 1/2 trial completes | ||||
| Also tested for | PDAC, PDAC - Pancreatic Ductal Adenocarcinoma and 8 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Non Small Cell Lung Cancer, Solid Tumors, Adult and 2 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021